Literature DB >> 114295

Auxanographic grouping and typing of Neisseria gonorrhoeae.

A T Hendry, I O Stewart.   

Abstract

Nearly 96% of 1297 Neisseria gonorrhoeae isolates in Hamilton were assigned to six major auxanographic groups (non-requiring or NR, Pro-, Orn-, Pro-Cit-Ura-, Orn-Ura-Hyx-, Cit-Ura-Hyx-) as established by requirements for none, or any one or more of proline, uracil, hypoxanthine, citrulline (Cit-), or citrulline replaceable by ornithine (Orn-) on chemically defined medium modified from Catlin (1973). Seven other groups, and strains not growing, accounted for 4.2%. The most common groups were Orn-Ura-Hyx- (25.6%) and Pro-Cit-Ura (31.8%). This latter group has not been previously described. These "Pro Cit/Orn Ura Hyx" criteria were among the most unequivocal to interpret; with rare exceptions for proline, a requirement was shown by absence of growth at any time in the zones of inoculation from a replicator. For some strains, some of the possible additional requirements (leucine, valine, isoleucine, glutamine, threonine, serine, histidine, etc.) could be less readily ascertained, because an occasional manifestation was to reduce the amount of growth, or to slow down the rate of growth, compared to complete medium. The first four of the six groups were the least fastidious, in that few strains had any additional requirements. About 2% of strains were inhibited by 0.25 mM phenylalanine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114295     DOI: 10.1139/m79-075

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  33 in total

1.  Cefaclor, an alternative to third generation cephalosporins for the treatment of gonococcal urethritis in the developing world?

Authors:  F Crabbé; T M Grobbelaar; E van Dyck; Y Dangor; M Laga; R C Ballard
Journal:  Genitourin Med       Date:  1997-12

2.  Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.

Authors:  M J van de Laar; Y T van Duynhoven; M Dessens; M van Santen; B van Klingeren
Journal:  Genitourin Med       Date:  1997-12

3.  Gonorrhoea: auxotypes, serovars, and clinical manifestations among female sex workers from Kinshasa, Zaïre.

Authors:  L Mukenge-Tshibaka; M Alary; E Van Dyck; M Laga; N Nzila
Journal:  Genitourin Med       Date:  1997-12

4.  Molecular and epidemiological analysis of penicillinase producing strains of Neisseria gonorrhoeae isolated in Canada 1976-84: evolution of new auxotypes and beta lactamase encoding plasmids.

Authors:  J R Dillon; M Pauzé; K H Yeung
Journal:  Genitourin Med       Date:  1986-06

5.  Auxotypes, plasmid contents, and serovars of gonococcal strains (PPNG and non-PPNG) from Jamaica.

Authors:  J R Dillon; M Carballo; S D King; A R Brathwaite
Journal:  Genitourin Med       Date:  1987-08

Review 6.  Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology.

Authors:  Magnus Unemo; Jo-Anne R Dillon
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

7.  Serological classification in relation to auxotypes, plasmid contents, and susceptibilities to antimicrobials of PPNG and non-PPNG strains isolated in Greece.

Authors:  G Tzanakaki; L Mavrommati; E Tzelepi; S Kolyva; E Fragouli
Journal:  Genitourin Med       Date:  1989-06

8.  Analysis of an outbreak of penicillinase-producing Neisseria gonorrhoeae in Rhode Island, 1987.

Authors:  B A Debuono; S M Opal; S K Sarafian; L W Lyhte
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

9.  Probenecid: antibacterial action against Neisseria gonorrhoeae and interaction with benzylpenicillin.

Authors:  B W Catlin
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

10.  Oxidation of D-lactate and L-lactate by Neisseria meningitidis: purification and cloning of meningococcal D-lactate dehydrogenase.

Authors:  A L Erwin; E C Gotschlich
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.